CALABRESI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.280
EU - Europa 1.016
AS - Asia 677
SA - Sud America 81
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 16
OC - Oceania 9
AN - Antartide 1
Totale 3.106
Nazione #
US - Stati Uniti d'America 1.251
RU - Federazione Russa 279
IT - Italia 239
PL - Polonia 226
SG - Singapore 216
CN - Cina 160
HK - Hong Kong 92
BR - Brasile 63
VN - Vietnam 63
KR - Corea 52
IE - Irlanda 48
DE - Germania 45
FR - Francia 41
SE - Svezia 41
CH - Svizzera 30
CA - Canada 23
GB - Regno Unito 22
IN - India 22
BD - Bangladesh 21
FI - Finlandia 20
JP - Giappone 13
JO - Giordania 11
AR - Argentina 9
AU - Australia 9
ID - Indonesia 9
NL - Olanda 9
ES - Italia 6
NG - Nigeria 5
BE - Belgio 4
EC - Ecuador 4
IQ - Iraq 4
UZ - Uzbekistan 3
ZA - Sudafrica 3
CI - Costa d'Avorio 2
CL - Cile 2
MX - Messico 2
PH - Filippine 2
PK - Pakistan 2
TN - Tunisia 2
TR - Turchia 2
UA - Ucraina 2
AG - Antigua e Barbuda 1
AL - Albania 1
AQ - Antartide 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
MU - Mauritius 1
MY - Malesia 1
PR - Porto Rico 1
TG - Togo 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.081
Città #
Santa Clara 266
Warsaw 224
Ashburn 174
Singapore 142
Hong Kong 81
Fairfield 73
San Jose 59
Chandler 52
Seoul 50
Dublin 48
Florence 47
Woodbridge 37
Seattle 36
Houston 34
Beijing 33
Hefei 32
Ann Arbor 30
Cambridge 30
Milan 30
Bern 28
Council Bluffs 24
Munich 24
Wilmington 24
Hanoi 21
Los Angeles 21
Buffalo 20
The Dalles 17
Dallas 16
New York 16
Paris 16
Moscow 15
Altamura 14
Lauterbourg 14
Lawrence 14
Rome 14
Ho Chi Minh City 13
Princeton 11
Tokyo 11
Turku 11
Bremen 10
Kent 9
Boston 8
Brooklyn 8
Melbourne 8
Mumbai 8
Turin 7
Clifton 6
Dong Ket 6
Jakarta 6
Montreal 6
Shanghai 6
São Paulo 6
Abuja 5
Bengaluru 5
Bologna 5
Cagliari 5
Chicago 5
Dearborn 5
Frankfurt am Main 5
London 5
Tianjin 5
Boardman 4
Brussels 4
Castel Maggiore 4
Da Nang 4
Helsinki 4
Phoenix 4
San Diego 4
Venice 4
Waltham 4
Brescia 3
Chennai 3
Figino 3
Hangzhou 3
Hillsboro 3
Orem 3
Padua 3
Redwood City 3
Shenzhen 3
Tashkent 3
Toronto 3
Yubileyny 3
Abidjan 2
Amsterdam 2
Ankara 2
Augusta 2
Baghdad 2
Basel 2
Birigui 2
Cantagallo 2
Chambersburg 2
City of London 2
Cusano Milanino 2
Dhaka 2
Ealing 2
Edmonton 2
Enid 2
Faisalabad 2
Falls Church 2
Fiesole 2
Totale 2.069
Nome #
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 335
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis 264
Characterization of novel molecular targets and mechanisms in Philadelphia-negative Myeloproliferative Neoplasms 261
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 261
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 218
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. 200
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 193
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature 187
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis 186
The MPL mutation 185
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs 169
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 158
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells 151
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 138
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes 106
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion 94
Totale 3.106
Categoria #
all - tutte 8.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202267 0 0 8 0 2 4 0 7 5 6 14 21
2022/2023268 15 51 14 22 15 34 30 14 29 2 9 33
2023/2024132 2 15 15 5 12 16 1 37 4 5 13 7
2024/2025859 27 72 44 131 212 128 18 41 54 38 42 52
2025/20261.046 112 109 101 79 117 42 130 49 72 58 51 126
2026/2027128 102 25 1 0 0 0 0 0 0 0 0 0
Totale 3.106